Zydus Cadila Covid vaccine likely to be ready by March 2021.

Phase-2 trials of Zydus Cadila's indigenous vaccine ZyCoV-D is moving in the right direction and the data will be available by the end of November and the vaccine is likely to be available by March 2021..

China's Experimental COVID-19 Vaccine Appears Safe In Early Trials Study.

COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no severe adverse reactions, its COVID-19 Vaccine...

EMA starts first rolling review of a COVID-19 vaccine in the EU.

EMA's human medicines committee has started the first rolling review of a COVID-19 vaccine, which is being developed by the company AstraZeneca in collaboration with the University of Oxford....

AstraZeneca: COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil & India.

The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical..

Second UK Covid-19 vaccine manufacturing site gets MHRA approval.

The second of two GMP manufacturing sites for the UK's specialist vaccines manufacturing equipment has been approved by the Medicines & Healthcare...

Recipharm signs agreement with Arcturus Therapeutics to support the manufacture of LUNAR -COV19 vaccine candidate.

Recipharm has entered into an agreement with Arcturus Therapeutics, a leading U.S. based clinical-stage messenger RNA medicines company focused on the development of infectious disease ...

Eisai enters joint research pact with four research organizations in Japan for development of therapeutics for novel COVID-19.

Eisai Co Ltd announced that it has entered into a joint research agreement with four research organizations in Japan concerning the Development of Therape...

BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2.

Pfizer Inc. and BioNTech SE announced the initiation of a rolling submission to the EMA for BNT162b2, the lead candidate from the companies vaccine...

Syngene joins global industry consortium to accelerate collaborative research in COVID-19 testing.

Demand for single-use assembly solutions in the biopharma industry continues to increase, with the market expected to be worth $26.89 billion by 2025.

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events.

Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival of Pharma, 05 – 16 October 2020...

Syntegon goes live at PACK EXPO Connects 2020.

PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions at the virtually..